We see a world where myopia is controlled earlier, easily, and more effectively.
Our eyesight is vital to learning and negotiating the world and largely impacts our potential to live full and productive lives. Myopia (short-sightedness) is the most common ocular disorder in the world, often with serious consequences. By 2050, it is estimated to affect one in two people, becoming one of the world’s leading causes of permanent blindness.
When our child is diagnosed with myopia, it’s vital to slow its progress early on. The sooner it is controlled, the better our chances of maintaining long-term sight and quality of life into adulthood. However, current myopia treatments can be invasive and are not always viable for children, especially the very young, limiting options for your child and their physician.
When childhood myopia is diagnosed, it’s vital to slow its progression early on. The sooner it is controlled, the better our chances of maintaining long-term sight and quality of life into adulthood. However, current myopia treatments are often invasive and not always viable for children, especially the very young, limiting options for the child and physician.
We see a world where childhood myopia is controlled early, easily and more effectively with positive life–changing impacts. And we’re working to address the global myopia epidemic with its enormous social and economic implications – by bringing the clinically proven, child-friendly Eyerising Myopia Management Device RLRL therapy to the next generation at home. Saving sight sooner makes a brighter future for all of us.
See us at upcoming events
References
- Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S, Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050, Ophthalmology, May 2016 Volume 123, Issue 5, Pages 1036?1042.
